{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-054549","form_type":"8-K","ticker":"ATEC","cik":"0001350653","company_name":"Alphatec Holdings, Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.053576+00:00","generated_at":"2026-06-02T17:00:52.073846+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ATEC Q1 revenue up 27% to $138M; raises FY 2024 guidance","bullets":["Surgical revenue grew 30% YoY on 23% volume increase and 6% higher average revenue per procedure.","GAAP net loss of $48M; adjusted EBITDA loss of $3M (2% margin), improving 450 bps YoY.","Full-year revenue guidance raised to $601M (from $595M); adjusted EBITDA guidance raised to $23M (from $22M).","Ending cash balance of $144M; deployed ~$60M in revenue-generating assets during Q1.","CEO Pat Miles cites clear line of sight to $1B revenue with innovative spine portfolio."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-054549","json":"https://secwatch.observer/filing/0000950170-24-054549.json","markdown":"https://secwatch.observer/filing/0000950170-24-054549.md","text":"https://secwatch.observer/filing/0000950170-24-054549.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1350653/000095017024054549/0000950170-24-054549-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1350653/000095017024054549/atec-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T17:00:52.073846+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"43c0af4b8770c974a87ca88dc357bd435ccd48a6","claim":"Alphatec Holdings, Inc. reported the fiscal year ended December 31, 2024 results: revenue $601 million. Guidance raised.","evidence_excerpt":"For the fiscal year ended December 31, 2024, the Company now expects total revenue to grow 25% to $601 million compared to the previous expectation of $595 million. This includes surgical revenue of $536 million and EOS revenue of $65 million. The Company now expects non-GAAP adjusted EBITDA of approximately $23 million compared to the previous expectation of $22 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1350653/000095017024054549/0000950170-24-054549-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2024"},{"label":"Revenue","value":"$601 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"90daa9ebbed6d0cfac70c8900610c791bc11322c","claim":"Alphatec Holdings, Inc. reported the quarter ended March 31, 2024 results: revenue $138 million, net income ($48) million.","evidence_excerpt":"First Quarter 2024 Financial Results Quarter Ended March 31, 2024 Total revenue $138 million GAAP gross margin 70% Non-GAAP gross margin 71% GAAP operating expenses $141 million Non-GAAP operating expenses $115 million GAAP net loss ($48) million Adjusted EBITDA ($3) million Adjusted EBITDA margin (2%) Ending cash balance $144 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1350653/000095017024054549/0000950170-24-054549-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$138 million"},{"label":"Net income","value":"($48) million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}